SynAct Pharma: Another SEK18m from Warrant Conversion - Redeye
Bildkälla: Stockfoto

SynAct Pharma: Another SEK18m from Warrant Conversion - Redeye

Redeye is optimistic about the second warrant conversion from HCM. This further improves SynAct's cash position with limited dilution.

Redeye is optimistic about the second warrant conversion from HCM. This further improves SynAct's cash position with limited dilution.
Börsvärldens nyhetsbrev